Lupin Pharmaceuticals has received final US FDA approval for its Valsartan and Hydrochlorothiazide tablets in 5 strengths. Subsequent to the approval, Lupin will market generic version of Novartis Pharmaceuticals’ Diovan HCT® tablets, the company said in a filing to the Bombay Stock Exchange.
Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.
or login http://www.epicresearch.co/
No comments:
Post a Comment